Co-administration of an allogenic blood stem cell transplant and sorafenib cured AML patients refractive to...
Up To Date
Latest News
Poxel S.A. is advancing its proof-of-concept type 2 diabetes programme imeglimin (PXL008) into Phase III...
Anticalin developer Pieris and Antibody-drug conjugate specialist Seattle Genetics have agreed to co-develop...
Italfarmaco SpA’s Givinostat, a small molecule histone deacetylase (HDAC) inhibitor in clinical testing...
German researchers have identified a target to switch off intestinal acute graft-versus-host disease (GVHD),...
The European Medicines Agency (EMA) has won a landmark battle about the amount of data from clinical dossiers...